We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Effects of the Chinese herbal formula 'Zuojin Pill' on the pharmacokinetics of dextromethorphan in healthy Chinese volunteers with CYP2D6*10 genotype.
- Authors
Qiu, Furong; Liu, Songcan; Miao, Ping; Zeng, Jin; Zhu, Leilei; Zhao, TongFang; Ye, Yujie; Jiang, Jian
- Abstract
Objective: Zuojin Pill has been shown to inhibit the cytochrome P450 (CYP) 2D6 isoenzyme in vitro. In Chinese individuals, CYP 2D6*10 is the most common allele with reduced enzyme activity. In this study, we investigated the pharmacokinetic interaction between Zuojin Pill and the sensitive CYP2D6 probe dextromethorphan in healthy Chinese volunteers with CYP2D6*10 genotype. Methods: A pharmacokinetics interaction study was carried out in three groups with CYP2D6*1/*1 ( n = 6), CYP2D6*1/*10 ( n = 6), and CYP2D6*10/*10 ( n = 6) genotypes. Each participant received a single oral dose of dextromethorphan (15 mg) followed by Zuojin Pill (3 g twice daily) for 7 days, and received 3 g Zuojin Pill with 15 mg dextromethorphan in the last day. Blood samples (0-24 h) and urine samples (0-12 h) were collected at baseline and after the administration of Zuojin Pill, and the samples' concentration of dextromethorphan and its main metabolite dextrorphan was determined. Results: Compared to baseline values, co-administration of Zuojin Pill (3 g twice daily) for 7 days increased the AUC of dextromethorphan [mean (90 % CI)] by 3.00-fold (2.49∼3.61) and 1.71-fold (1.42∼2.06), and decreased oral clearance(CL/F) by 0.27-fold (0.2-0.40) and 0.57-fold (0.48-0.67) in the participants with CYP2D6*1/*1 and CYP2D6*1/*10 genotypes, respectively. In contrast, no significant change was observed in these pharmacokinetic parameters of the participants with CYP2D6*10/*10 genotype. Conclusion: These data demonstrated that administration of Zuojin Pill inhibited moderately CYP2D6-mediated metabolism of dextromethorphan in healthy volunteers. The inhibitory influence of CYP2D6 was greater in CYP2D6*1/*1 and CYP2D6*1/*10 groups than CYP2D6 *10/*10 group.
- Subjects
COMBINATION drug therapy; BOTANIC medicine; TREATMENT effectiveness; DEXTROMETHORPHAN; GENOTYPES
- Publication
European Journal of Clinical Pharmacology, 2016, Vol 72, Issue 6, p689
- ISSN
0031-6970
- Publication type
Article
- DOI
10.1007/s00228-016-2048-7